Shiloh
Editor, Senior Moderator
Source: https://www.cnbc.com/2021/08/06/south-african-study-shows-high-covid-protection-from-jj-shot.html
South African study shows high Covid protection from J&J shot
Published Fri, Aug 6 202110:57 AM EDT
Reuters
Key Points
The J&J vaccine was administered to healthcare workers from mid-February in a research study, which was completed in May, with 477,234 health workers vaccinated, joint lead investigator Glenda Gray told a media briefing.
South Africa’s health regulator approved the J&J shot in April, and it is being used in the national vaccine program alongside Pfizer’s.
Johnson & Johnson’s Covid-19 vaccine is working well in South Africa, offering protection against severe disease and death, the co-head of a trial in the country said on Friday.
The J&J vaccine was administered to healthcare workers from mid-February in a research study, which was completed in May, with 477,234 health workers vaccinated, joint lead investigator Glenda Gray told a media briefing.
South Africa’s health regulator approved the J&J shot in April, and it is being used in the national vaccine program alongside Pfizer’s...
South African study shows high Covid protection from J&J shot
Published Fri, Aug 6 202110:57 AM EDT
Reuters
Key Points
The J&J vaccine was administered to healthcare workers from mid-February in a research study, which was completed in May, with 477,234 health workers vaccinated, joint lead investigator Glenda Gray told a media briefing.
South Africa’s health regulator approved the J&J shot in April, and it is being used in the national vaccine program alongside Pfizer’s.
Johnson & Johnson’s Covid-19 vaccine is working well in South Africa, offering protection against severe disease and death, the co-head of a trial in the country said on Friday.
The J&J vaccine was administered to healthcare workers from mid-February in a research study, which was completed in May, with 477,234 health workers vaccinated, joint lead investigator Glenda Gray told a media briefing.
South Africa’s health regulator approved the J&J shot in April, and it is being used in the national vaccine program alongside Pfizer’s...